RHON-KLINIKUM AG Unsponsored ADR
RKAGY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,596 | $1,464 | $1,446 | $1,591 |
| % Growth | 9% | 1.2% | -9.1% | – |
| Cost of Goods Sold | $1,424 | $1,315 | $447 | $430 |
| Gross Profit | $172 | $149 | $1,000 | $183 |
| % Margin | 10.8% | 10.2% | 69.1% | 11.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $69 | $70 | $22 | $20 |
| SG&A Expenses | $69 | $70 | $22 | $20 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $54 | $38 | $942 | $132 |
| Operating Expenses | $124 | $108 | $963 | $152 |
| Operating Income | $48 | $40 | $36 | $31 |
| % Margin | 3% | 2.8% | 2.5% | 1.9% |
| Other Income/Exp. Net | $8 | $7 | -$2 | -$3 |
| Pre-Tax Income | $56 | $48 | $34 | $27 |
| Tax Expense | $11 | $8 | $7 | -$3 |
| Net Income | $43 | $39 | $25 | $28 |
| % Margin | 2.7% | 2.6% | 1.7% | 1.8% |
| EPS | 0.34 | 0.29 | 0.19 | 0.21 |
| % Growth | 17.2% | 52.6% | -9.5% | – |
| EPS Diluted | 0.34 | 0.29 | 0.19 | 0.21 |
| Weighted Avg Shares Out | 129 | 134 | 134 | 134 |
| Weighted Avg Shares Out Dil | 129 | 134 | 134 | 134 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | $11 | $1 | $1 |
| Interest Expense | $3 | $4 | $4 | $3 |
| Depreciation & Amortization | $63 | $66 | $66 | $70 |
| EBITDA | $122 | $117 | $98 | $100 |
| % Margin | 7.7% | 8% | 6.8% | 6.3% |